After training initially with one of the top biotech patent groups in the U.S. and practicing in large general practice firms for over 20 years, Carl has the experience to meet the intellectual property needs of startups, mid-size R&D companies, large  biotherapeutic and pharmaceutical companies, and top tier, research-intensive universities. He enjoys doing single-project work, as well as comprehensive counseling and portfolio development for startups and growing companies.

Carl has counseled scientific founders on initial protection strategies for their platform technology (timing, scope of disclosure, landscape analysis, ownership issues), developed licensing programs for diagnostic technology, and evaluated lifecycle management programs for marketed human therapeutics.  He also has evaluated patent and patent litigation issues involving manufacturing and energy, including mechanical and chemical areas.  Carl has assisted clients at every stage of the business lifecycle, from discovery, through development and commercialization.

 

Carl’s experience allows him to add value as a trusted member of the business team for his clients, and not merely as a hired legal technician.

 

 

Education

Boston University School of Law, J.D. (1997)

Duke University, M.S., Biochemistry (1994)

University of Alabama, Birmingham, M.S., Biology

(1990)

Wake Forest University, B.S., Biology (1986)

 

Bar Admissions

U.S. Patent and Trademark Office (1998)

Virginia (1997)

North Carolina (1999)

 

Court Admissions

West District of North Carolina (2014)

Fourth Circuit Court of Appeals

 

Prior Work Experience

Sterne, Kessler, Goldstein & Fox, PLLC (1997-1999)

Kilpatrick Stockton, LLP (now Kilpatrick Townsend)

(1999-2001)

Womble Bond Dickinson (US) LLP (2001-2019)